In terms of CNS demyelinating diseases, we recently reported that CSF neopterin levels are elevated in patients with AQP4-IgG-positive NMOSD and MOGAD compared to those in patients with multiple sclerosis [7]. This evidence concerns the gene AQP4 and demyelinating disease of central nervous system.